References
  1. Alliance for Aging Research. The Silver Book: Valve Disease. 2018;11. Available at: https://www.agingresearch.org/document/the-silver-book-valve-disease/ (Accessed: 15 August 2020)
  2. Fadi G, Jad O ’Percutaneous Mitral Valve Therapies: The Old, Current, and Future’, American College of Cardiology. Available at: https://www.acc.org/latest-in-cardiology/articles/2020/07/31/08/28/percutaneous-mitral-valve-therapie. (Accessed: 20 August 2020)
  3. Khan F, Winkel M, Ong G, et al. Percutaneous Mitral Edge-to-Edge Repair: State of the Art and a Glimpse to the Future. Front Cardiovasc Med. 2019;6:122. DOI:10.3389/fcvm.2019.00122
  4. Gallegos RP, Bolman RM. Heart Valve Disease. In: Iaizzo P.A. (eds) Handbook of Cardiac Anatomy, Physiology, and Devices. Humana Press. 2005. Available at: https://doi.org/10.1007/978-1-59259-835-9_27
  5. Brinkley DM, Gelfand EV. Valvular heart disease: Classic teaching and emerging paradigms. Am J Med. 2013;126(12):1035–42. Available at: http://dx.doi.org/10.1016/j.amjmed.2013.05.022
  6. Freed LA, Levy D, Levine RA, et al. Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med. 1999;341(1):1-7. DOI:10.1056/NEJM199907013410101
  7. El Sabbagh A, Reddy YNV, Nishimura RA. Mitral Valve Regurgitation in the Contemporary Era: Insights Into Diagnosis, Management, and Future Directions. JACC Cardiovasc Imaging . 2018;11(4):628-643. DOI:10.1016/j.jcmg.2018.01.009
  8. Wilkinson IB, Raine T, Wiles K et al. Oxford Handbook of Clinical Medicine, 10th edn. Oxford University Press. 2017 Doi: 10.1093/med/9780199689903.001.0001
  9. Nielsen SL. Current status of transcatheter mitral valve repair therapies - From surgical concepts towards future directions. Scand Cardiovasc J. 2016;50(5-6):367-376. DOI:10.1080/14017431.2016.1248482
  10. Ben Zekry S, Lang RM, Sugeng L, et al. Mitral annulus dynamics early after valve repair: preliminary observations of the effect of resectional versus non-resectional approaches. J Am Soc Echocardiogr. 2011;24(11):1233-1242. doi:10.1016/j.echo.2011.08.010
  11. Veronesi F, Corsi C, Sugeng L, et al. A study of functional anatomy of aortic-mitral valve coupling using 3D matrix transesophageal echocardiography. Circ Cardiovasc Imaging. 2009;2(1):24-31.doi:10.1161/CIRCIMAGING.108.785907
  12. Asgar AW, Mack MJ, Stone GW. Secondary mitral regurgitation in heart failure: pathophysiology, prognosis, and therapeutic considerations. J Am Coll Cardiol. 2015;65(12):1231-1248. doi:10.1016/j.jacc.2015.02.009
  13. Tsang W. Recent advances in understanding and managing mitral valve disease. F1000Res. 2019;8:F1000 Faculty Rev-1686. doi:10.12688/f1000research.16066.1
  14. Rahman S, Eid N, Murarka S, Heuser RR. Remodeling of the mitral valve using radiofrequency energy: review of a new treatment modality for mitral regurgitation. Cardiovasc Revasc Med. 2010;11(4):249-259. doi:10.1016/j.carrev.2009.10.004
  15. Maeder MT, Weber L, Buser M, et al. Pulmonary Hypertension in Aortic and Mitral Valve Disease. Front Cardiovasc Med. 2018;5:40. doi:10.3389/fcvm.2018.00040
  16. Kaplan EL. Pathogenesis of acute rheumatic fever and rheumatic heart disease: evasive after half a century of clinical, epidemiological, and laboratory investigation. Heart. 2005;91(1):3-4. doi:10.1136/hrt.2004.034744
  17. Bryant P, Robins-Browne R, Carapetis J, Curtis N.Some of the People, Some of the Time. Circulation . 2009;119(5), pp.742-753.
  18. Anastasiou-Nana MI, Anderson JL, Carlquist JF, Nanas JN. HLA-DR typing and lymphocyte subset evaluation in rheumatic heart disease: a search for immune response factors. Am Heart J. 1986;112(5):992-997. doi:10.1016/0002-8703(86)90311-x
  19. Engel ME, Stander R, Vogel J, Adeyemo AA, Mayosi BM. Genetic susceptibility to acute rheumatic fever: a systematic review and meta-analysis of twin studies. PLoS One. 2011;6(9):e25326. doi:10.1371/journal.pone.0025326
  20. Wu S, Chai A, Arimie S, et al. Incidence and treatment of severe primary mitral regurgitation in contemporary clinical practice. Cardiovasc Revasc Med. 2018;19(8):960-963. doi:10.1016/j.carrev.2018.07.021
  21. Maganti K, Rigolin VH, Sarano ME, Bonow RO. Valvular heart disease: diagnosis and management. Mayo Clin Proc. 2010;85(5):483-500. doi:10.4065/mcp.2009.0706
  22. Gammie JS, O’Brien SM, Griffith BP, Peterson ED. Surgical treatment of mitral valve endocarditis in North America. Ann Thorac Surg. 2005;80(6):2199-2204. doi:10.1016/j.athoracsur.2005.05.036
  23. Sternik L, Zehr KJ, Orszulak TA, Mullany CJ, Daly RC, Schaff HV. The advantage of repair of mitral valve in acute endocarditis. J Heart Valve Dis. 2002;11(1):91-98.
  24. Toyoda N, Itagaki S, Egorova NN, et al. Real-world outcomes of surgery for native mitral valve endocarditis. J Thorac Cardiovasc Surg. 2017;154(6):1906-1912.e9. doi:10.1016/j.jtcvs.2017.07.077
  25. de Kerchove L, Vanoverschelde JL, Poncelet A, et al. Reconstructive surgery in active mitral valve endocarditis: feasibility, safety, and durability [published correction appears in Eur J Cardiothorac Surg. 2007 Sep;32(3):557]. Eur J Cardiothorac Surg. 2007;31(4):592-599. doi:10.1016/j.ejcts.2007.01.002
  26. Aranki SF, Adams DH, Rizzo RJ, et al. Determinants of early mortality and late survival in mitral valve endocarditis. Circulation. 1995;92(9 Suppl):II143-II149. doi:10.1161/01.cir.92.9.143
  27. Shah M, Jorde UP. Percutaneous Mitral Valve Interventions (Repair): Current Indications and Future Perspectives. Front Cardiovasc Med . 2019;6:88. Published 2019 Jul 12. doi:10.3389/fcvm.2019.00088
  28. Kelley C, Lazkani M, Farah J, Pershad A. Percutaneous mitral valve repair: A new treatment for mitral regurgitation. Indian Heart J . 2016;68(3):399-404. doi:10.1016/j.ihj.2015.08.025
  29. Pepe M, De Cillis E, Acquaviva T, et al. Percutaneous Edge-to-Edge Transcatheter Mitral Valve Repair: Current Indications and Future Perspectives. Surg Technol Int . 2018;32:201-207.
  30. Jilaihawi H, Hussaini A, Kar S. MitraClip: a novel percutaneous approach to mitral valve repair. J Zhejiang Univ Sci B . 2011;12(8):633-637. doi:10.1631/jzus.B1101009
  31. Mangieri A, Laricchia A, Giannini F, et al. Emerging Technologies for Percutaneous Mitral Valve Repair. Front Cardiovasc Med . 2019;6:161. Published 2019 Nov 6. doi:10.3389/fcvm.2019.00161
  32. Shamoun FE, Craner RC, Seggern RV, Makar G, Ramakrishna H. Percutaneous and minimally invasive approaches to mitral valve repair for severe mitral regurgitation-new devices and emerging outcomes.Ann Card Anaesth . 2015;18(4):528-536. doi:10.4103/0971-9784.166462
  33. Khalique OK, Hahn RT. Percutaneous Mitral Valve Repair: Multi-Modality Cardiac Imaging for Patient Selection and Intra-Procedural Guidance. Front Cardiovasc Med. 2019;6:142. Published 2019 Sep 20. doi:10.3389/fcvm.2019.00142
  34. U.S National Library of Medicine-ClinicalTrials.gov (2020) A Clinical Evaluation of the Safety and Effectiveness of the MitraClip System in the Treatment of Clinically Significant Functional Mitral Regurgitation (Reshape-HF2), Available at:https://clinicaltrials.gov/ct2/show/NCT02444338?term=mitraclip&cond=Mitral+Regurgitation&draw=2&rank=8#moreinfo (Accessed: 6 August 2020).
  35. U.S National Library of Medicine-ClinicalTrials.gov (2020) MitraClip for the Treatment of Moderate Functional Mitral Regurgitation: EVOLVE-MR (EVOLVE-MR), Available at: https://clinicaltrials.gov/ct2/show/NCT03705312?term=mitraclip&cond=Mitral+Regurgitation&draw=2&rank=16 (Accessed: 6 August 2020).
  36. Grayburn PA, Sannino A, Packer M. Proportionate and Disproportionate Functional Mitral Regurgitation: A New Conceptual Framework That Reconciles the Results of the MITRA-FR and COAPT Trials. JACC Cardiovasc Imaging. 2019;12(2):353-362. doi:10.1016/j.jcmg.2018.11.006
  37. Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135(25):e1159-e1195. doi:10.1161/CIR.0000000000000503
  38. Praz F, Spargias K, Chrissoheris M, et al. Compassionate use of the PASCAL transcatheter mitral valve repair system for patients with severe mitral regurgitation: a multicentre, prospective, observational, first-in-man study. Lancet. 2017;390(10096):773-780. doi:10.1016/S0140-6736(17)31600-8
  39. Corpataux N, Winkel MG, Kassar M, Brugger N, Windecker S, Praz F. The PASCAL Device-Early Experience with a Leaflet Approximation Device: What Are the Benefits/Limitations Compared with the MitraClip?. Curr Cardiol Rep. 2020;22(8):74. Published 2020 Jun 27. doi:10.1007/s11886-020-01305-1
  40. Mitral Stenosis: Percutaneous Transvenous Mitral Commissurotomy - The Cardiology Advisor [Internet]. The Cardiology Advisor. 2020. Available from: https://www.thecardiologyadvisor.com/home/decision-support-in-medicine/cardiology/mitral-stenosis-percutaneous-transvenous-mitral-commissurotomy/ (Accessed: 13 August 2020)
  41. Saccocci M, Taramasso M, Maisano F. Percutaneous mitral valvuloplasty in the modern era. Kardiol Pol. 2018;76(5):819-820. doi:10.5603/KP.2018.0095
  42. Farman MT, Khan N, Sial JA, et al. Predictors of successful percutaneous transvenous mitral commissurotomy using the Bonhoeffer Multi-Track system in patients with moderate to severe mitral stenosis: Can we see beyond the Wilkins score?. Anatol J Cardiol. 2015;15(5):373-379. doi:10.5152/akd.2014.5466
  43. Firouzi A, Samiei N, Ahmadi S, et al. Percutaneous Transluminal Mitral Commissurotomy in Pregnant Women with Severe Mitral Stenosis. J Tehran Heart Cent. 2019;14(1):12-17.
  44. Inoue K, Owaki T, Nakamura T, Kitamura F, Miyamoto N. Clinical application of transvenous mitral commissurotomy by a new balloon catheter. The Journal of Thoracic and Cardiovascular Surgery. 1984;87(3):394-402.
  45. Adhikari CM, Malla R, Rajbhandari R, et al. Percutaneous transvenous mitral commissurotomy in juvenile mitral stenosis. Cardiovasc Diagn Ther. 2016;6(1):20-24. doi:10.3978/j.issn.2223-3652.2015.12.07
  46. Harrison JK, Wilson JS, Hearne SE, Bashore TM. Complications related to percutaneous transvenous mitral commissurotomy. Cathet Cardiovasc Diagn. 1994;Suppl 2:52-60.
  47. Murthy Jayanthi Sriram SN, Venkata BJ, Sadagopan T, Ramamurthy MT. Immediate, intermediate and long term clinical outcomes of percutaneous transvenous mitral commissurotomy. Int J Cardiol Heart Vasc. 2015;6:66-70. Published 2015 Jan 15. doi:10.1016/j.ijcha.2015.01.006
  48. Reyes VP, Raju BS, Wynne J, et al. Percutaneous balloon valvuloplasty compared with open surgical commissurotomy for mitral stenosis. N Engl J Med. 1994;331(15):961-967. doi:10.1056/NEJM199410133311501
  49. Walther C, Fichtlscherer S, Holubec T, Vasa-Nicotera M, Arsalan M, Walther T. New developments in transcatheter therapy of mitral valve disease. J Thorac Dis. 2020;12(4):1728-1739. doi:10.21037/jtd.2019.12.137
  50. Bapat V, Rajagopal V, Meduri C, et al. Early Experience With New Transcatheter Mitral Valve Replacement. J Am Coll Cardiol. 2018;71(1):12-21. doi:10.1016/j.jacc.2017.10.061
  51. Del Val D, Ferreira-Neto AN, Wintzer-Wehekind J, et al. Early Experience With Transcatheter Mitral Valve Replacement: A Systematic Review. J Am Heart Assoc. 2019;8(17):e013332. doi:10.1161/JAHA.119.013332
  52. Webb JG, Murdoch DJ, Boone RH, et al. Percutaneous Transcatheter Mitral Valve Replacement: First-in-Human Experience With a New Transseptal System. J Am Coll Cardiol. 2019;73(11):1239-1246. doi:10.1016/j.jacc.2018.12.065
  53. Báez-Ferrer N, Izquierdo-Gómez MM, Marí-López B, et al. Clinical manifestations, diagnosis, and treatment of ischemic mitral regurgitation: a review. J Thorac Dis. 2018;10(12):6969-6986. doi:10.21037/jtd.2018.10.64
  54. Schnittman SR, Itagaki S, Toyoda N, Adams DH, Egorova NN, Chikwe J. Survival and long-term outcomes after mitral valve replacement in patients aged 18 to 50 years. J Thorac Cardiovasc Surg . 2018;155(1):96-102.e11. doi:10.1016/j.jtcvs.2017.08.018
  55. Winkel MG, Praz F, Wenaweser P. Mitral and Tricuspid Transcatheter Interventions Current Indications and Future Directions. Front Cardiovasc Med . 2020;7:61. Published 2020 May 15. doi:10.3389/fcvm.2020.00061
  56. De Bonis M, Al-Attar N, Antunes M, et al. Surgical and interventional management of mitral valve regurgitation: a position statement from the European Society of Cardiology Working Groups on Cardiovascular Surgery and Valvular Heart Disease. Eur Heart J. 2016;37(2):133-139. doi:10.1093/eurheartj/ehv322
  57. Van Praet KM, Stamm C, Sündermann SH, et al. Minimally Invasive Surgical Mitral Valve Repair: State of the Art Review [published correction appears in Interv Cardiol. 2018 May;13(2):99]. Interv Cardiol. 2018;13(1):14-19. doi:10.15420/icr.2017:30:1
  58. Wolfe JA, Malaisrie SC, Farivar RS, et al. Minimally Invasive Mitral Valve Surgery II: Surgical Technique and Postoperative Management. Innovations (Phila). 2016;11(4):251-259. doi:10.1097/IMI.0000000000000300
  59. Marin Cuartas M, Javadikasgari H, Pfannmueller B, et al. Mitral valve repair: Robotic and other minimally invasive approaches. Prog Cardiovasc Dis. 2017;60(3):394-404. doi:10.1016/j.pcad.2017.11.002
  60. Axtell AL, Moonsamy P, Dal-Bianco JP, Passeri JJ, Sundt TM, Melnitchouk S. Minimally Invasive Nonresectional Mitral Valve Repair Can Be Performed With Excellent Outcomes. Ann Thorac Surg. 2020;109(2):437-444. doi:10.1016/j.athoracsur.2019.07.029
  61. Kastengren M, Svenarud P, Ahlsson A, Dalén M. Minimally invasive mitral valve surgery is associated with a low rate of complications. J Intern Med. 2019;286(6):614-626. doi:10.1111/joim.12974
  62. Grant SW, Hickey GL, Modi P, Hunter S, Akowuah E, Zacharias J. Propensity-matched analysis of minimally invasive approach versus sternotomy for mitral valve surgery. Heart. 2019;105(10):783-789. doi:10.1136/heartjnl-2018-314049
  63. Sakaguchi T, Totsugawa T, Kuinose M, et al. Minimally Invasive Mitral Valve Repair Through Right Minithoracotomy - 11-Year Single Institute Experience. Circ J. 2018;82(6):1705-1711. doi:10.1253/circj.CJ-17-1319
  64. Němec P, Ondrášek J. Surgical treatment of mitral regurgitation.Cor et Vasa 2017; 59(1): 92-96. doi:10.1016/j.crvasa.2017.01.017
  65. Liu J, Chen B, Zhang YY, et al. Mitral valve replacement via minimally invasive totally thoracoscopic surgery versus traditional median sternotomy: a propensity score matched comparative study. Ann Transl Med. 2019;7(14):341. doi:10.21037/atm.2019.07.07
  66. Sündermann SH, Sromicki J, Rodriguez Cetina Biefer H, et al. Mitral valve surgery: right lateral minithoracotomy or sternotomy? A systematic review and meta-analysis. J Thorac Cardiovasc Surg. 2014;148(5):1989-1995.e4. doi:10.1016/j.jtcvs.2014.01.046
  67. Ding C, Jiang DM, Tao KY, et al. Anterolateral minithoracotomy versus median sternotomy for mitral valve disease: a meta-analysis. J Zhejiang Univ Sci B. 2014;15(6):522-532. doi:10.1631/jzus.B1300210
  68. ISRCTN Registry (2020) Minimally invasive thoracoscopically-guided right minithoracotomy versus conventional sternotomy for mitral valve repair: a multicentre randomised controlled trial (UK Mini Mitral)., Available at: http://www.isrctn.com/ISRCTN13930454 (Accessed: 1 September 2020).
  69. Tonutti M, Elson DS, Yang GZ, Darzi AW, Sodergren MH. The role of technology in minimally invasive surgery: State of the art, recent developments and future directions. Postgrad Med J. 2017;93(1097):159–67.
  70. Hawkins RB, Mehaffey JH, Mullen MG, et al. A propensity matched analysis of robotic, minimally invasive, and conventional mitral valve surgery. Heart. 2018;104(23):1970-1975. doi:10.1136/heartjnl-2018-313129
  71. Gillinov AM, Mihaljevic T, Javadikasgari H, et al. Early results of robotically assisted mitral valve surgery: Analysis of the first 1000 cases. J Thorac Cardiovasc Surg. 2018;155(1):82-91.e2. doi:10.1016/j.jtcvs.2017.07.037